Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

NCT07158021 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
OTHER: Electronic Health Record Review
DRUG: Goserelin
DRUG: Leuprolide
OTHER: Questionnaire Administration

Sponsor

University of Michigan Rogel Cancer Center